Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(10 sites)
United States
Mayo Clinic Phoenix, Phoenix, Arizona Providence Medical Foundation, Fullerton, California UCLA - JCCC Clinical Research Unit, Los Angeles, California Torrance Memorial Physician Network, Torrance, California Mayo Clinic Jacksonville, Jacksonville, Florida Florida Cancer Specialists Lake Nona Drug Development Unit, Orlando, Florida Mayo Clinic Rochester, Rochester, Minnesota Virginia Cancer Specialists, Lexington, Virginia Canada
University Health Network, Princess Margaret Cancer Centre, Toronto, Ontario McGill University Health Centre, Montreal, Quebec